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Abstract
We report a short-statured, 39-year-old male presenting with recurrent kidney stones, history of refractory rickets, and bone deformity. He 
had been consuming multiple doses of calcium supplements and multiple courses of vitamin D over past 30 years beforeprior to reporting in 
our clinic without any significant laboratory or clinical improvement. The patient was diagnosed as having Fanconi’s syndrome attributable 
to  Wilson’s disease. This patient highlighted that in case of resistant rickets, a high index of uncertainty must be invoked for Wilson’s disease. 
Appropriate timely recognition of this entity results in prompt ministrations and prevention of disability. We also presented and discussed 
reviews on Wilson’s disease from literature.
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Introduction
Vitamin D deficiency because of inadequate serum levels is 
the most common cause of rickets that becomes apparent in 
the early years (1).
A comprehensive inspection of other etiologies of rickets 
is suggested in patients who are intractable to the replace-
ment of vitamin D, including hypophosphatemic rickets, 
renal tubular acidosis (RTA), renal osteodystrophy, and vita-
min D-resistant rickets (1–5).
Although infrequent, Fanconi’s syndrome is a signifi-
cant cause of hypophosphatemic rickets. It is described as 
proximal RTA when presented with other proximal tubular 
defects such as aminoaciduria, phosphaturia, glucosuria, 
and uricosuria (6).
Fanconi’s syndrome occurs either as a primary or second-
ary type and causes derangement in the functioning of renal 
tubular cells. Some toxic metabolic substances also cause this 
syndrome such as in Wilson’s disease.
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Wilson’s disease is an inherited disease. Generally, it pres-
ents with hepatic and neuropsychiatric expressions because 
of excessive deposition of copper in organs due to defect 
of copper transport by hepatic lysosomes (7). Extrahepatic 
manifestations, including renal and osteoarticular disorders, 
although described infrequently, present as features of Wil-
son’s disease (8–10).
We present a 38-year-old male with rickets refractory to 
replacement of vitamin D because of Fanconi’s syndrome 
secondary to Wilson’s disease. A written informed consent 
was obtained from the patient, who was informed that the 
data could be submitted for publication.
Case Report
A 39-year-old male, third born from a second consanguin-
eous marriage, was referred to our clinic for evaluation of 
proteinuria. He had a history of recurrent kidney stone for-
mation, with long-term generalized weakness, pain in bones, 
progressive struggling in walking, and emergence of bone 
deformity in the extremities.
According to the patient, the stones passed with conser-
vative measures but were neither retrieved nor were any bio-
chemical studies conducted. 
His symptoms appeared at about 10 years of age with pain 
in bones. He was unable to walk properly since adulthood. 
He had bowing of the legs, which started in childhood and 
had gradually progressed to the present status. He was not 
able to walk without support for the past 15 years.
He was unable to attend and finish schooling after 8th 
grade. There was no history of involuntary movement, sei-
zures, or polyuria.
He had been treated with multiple courses of calcium 
supplements and vitamin D for past 30 years before report-
ing to our clinic but without any notable clinical or testing 
improvement.
One of his brothers had died at the age of 40 after rapid 
evolution of jaundice and severe ascites, but no conclusive 
diagnosis was made at that time.
General physical examination of our patient presented 
non-icteric, well-oriented male with severe short stature, 
height being 141 cm and weight as 45 kg. Vital signs were sta-
ble. Ophthalmic examination depicted presence of Kayser–
Fleischer (K-F) rings (Figure 1), which was later confirmed 
by ophthalmologist on slit lamp examination.
The abdomen was protuberant without any organomegaly. 
Secondary sexual characters were well developed.
All muscle groups were atrophied. Rachitic changes were 
noted, which included lordosis, genu valgum, prominent 
costo-chondral junction, and several bone deformities. The 
bones were tender on palpation. 
Neurological examination had no sign of cerebellar dys-
function, including extra pyramidal involvement and ataxia. 
The motor system evidenced normal reflexes and tones, 
muscle force was 3/5 in the lower limbs and 4/5 in the upper 
limbs.
Clinical examination established diagnosis of rickets. The 
patient depicted severe bowing of the upper and lower limbs 
and marked generalized osteopenia (Figure 2). Bony fusion 
and significant osteoarthritis was observed in the larger 
joints, with apparent presence in his knees. Angulation of 
the carpal bones and squaring in the head of the metacarpal 
bones was demonstrated. Severe deformity of the rib cage, 
inward bowing of the ribs, and marked kyphoscoliosis were 
also analyzed.
Laboratory investigations
Laboratory analyses revealed the following results: level of 
25-hydroxyvitamin D [25(OH)D] was adequate (52 ng/dL), 
with normal corrected calcium (10.24 mg/dL), phosphate 
(2.6 mg/dL), albumin (3.8 g/dL), blood Urea (17.7 mg/dL), 
creatinine (0.6 mg/dL), creatinine phosphokinase (59 IU/L), 
lactate dehydrogenase (426 IU/L), sodium (143 mEq/L), 
potassium (3.4 mEq/L; normal range: 3.6–5.0 mEq/L).
Further analyses depicted the following values: white 
blood corpuscle (WBC) = 7100/mm3, hemoglobin = 16 g/
dL, mean corpuscular volume (MCV) = 87.8 Fl, mean cor-
puscular hemoglobin (MCH) = 30.5, mean corpuscular 
hemoglobin concentration (MCHC) = 34.7, platelet count 
= 138,000/mm3, urine analysis (specific gravity = 1005, gly-
cosuria = 2+ [corresponding blood sugar was normal], pro-
teinuria = 1+, triple phosphate crystals present, and pH = 
8), and  C-reactive protein (CRP) = negative. The erythrocyte 
sedimentation rate (ESR) was 3 mm in the first minute, pro-
thrombin time = 14.7 s, partial thromboplastin time = 35 s, 
Figure 1: Ophthalmic examination shows presence of Kay-
ser–Fleischer (K-F) rings.
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to 110), serum bicarbonate = 13.8 mEq/L, urine chloride = 
135 mEq/L (98–107 mEq/L), urine potassium = 28.8 MEq/24 
h, urine anion gap = +31.
Capillary serum and urine electrophoresis analysis were 
normal. Serum copper (40 µg/dL), ceruloplasmin (13 mg/
dL) (normal range: 18–35 mg/dL), and 24-h urine copper 
was 220 mcg (normal value is up to 70 mcg/24 h). Glycos-
uria (1.83  g/L) was found on urinalysis with normal blood 
glucose.
Laboratory test data were compatible with normal anion 
gap RTA. According to the laboratory data, Fanconi’s syn-
drome due to Wilson’s disease was suspected clinically.
An abdominal ultrasound examination of the patient 
revealed multiple cortical cysts along with multiple small size 
stones in his right kidney. The liver parenchyma appeared to 
be having a heterogeneous and coarse architecture; the out-
line appeared markedly nodular, suggestive of chronic paren-
chymal liver disease, that is, liver cirrhosis. The spleen and 
portal vein were normal. Upper gastrointestinal endoscopy 
was also normal. However, the ammonium chloride chal-
lenge test was positive, indicating proximal tubular dysfunc-
tion, and the diagnosis of Wilson’s disease was confirmed 
after ophthalmological consultation.
The patient was placed on the replacement therapy of 
calcium, phosphate, and vitamin D along with replacement 
of alkali. He was also started with zinc acetate, 50 mg three 
times a day, and D-penicillamine, 250 mg/day, which was 
gradually increased to 750 mg/day given in divided doses, 
along with 20 mg/day of oral pyridoxine. 
Discussion and Review of Literature
In 1912, Wilson (11) reported progressive lenticular degen-
eration as a noticeable clinical entity, when he described four 
patients with this familial but not hereditary disease. Since 
then, significant progress has been made to our understand-
ing of the disease (12).
The global prevalence of Wilson’s disease is figured as 
12–30 patients per million populations, although clinical 
profile in terms of varying presentations is presumed to be 
under-publicized, and in Iran, its accurate prevalence is still 
not known (13).
In 1929, Vogt et al. (13) explained copper overload as the 
cause of the disease. In 1985, “Wilson gene” was mapped, 
and in 1993, ATP7B gene was cloned. Deficit of ATP7B 
decreases the secretion of copper in bile. Toxic accumulation 
of excess copper either as free or in bounded form damages 
organs. Despite variability in phenotypic expression, the dis-
ease progresses insidiously and is perpetual with wide clinical 
spectrum (12).
Generally, the first symptoms are hepatic in 40–45% and 
neurological in 45% of patients. Renal or osteomuscular 
findings as initial presentation are rarely reported.
SGOT = 66 U/L, SGPT = 54 U/L, bilirubin total = 2.04 mg/
dL, direct bilirubin = 0.63 mg/dL, serum alkaline phospha-
tase levels were elevated at 312 IU/L, and lactate dehydroge-
nase (LDH) = 496 U/L. 
Further laboratory investigations revealed that viral serol-
ogies for human immunodeficiency virus (HIV), hepatitis B 
antigen, and anti-hepatitis C virus Ab were negative. Upper 
gastrointestinal endoscopy was also within normal limits. 
The 24-h urinalysis established the following parameters: 
urine volume = 2000 cc; creatinine = 380 mgl(for males 97 
to 137 ml/min); protein = 860 mg/day(less than 80 mg per 
24 hrs); calcium = 95 mg/day (normal range: 100–300 mg/
day); uric acid = 228 mg/day (normal range: 250–750 mg/
day); phosphate = 0.729 mg/day (normal range: 400–1300 
mg/day); and magnesium = 45 mg/day (normal range: 
71–121 mg/day. 
Further tests presented antismooth muscle antibodies 
(ASMA) = negative, antinuclear antibodies (ANA) = 0.4 U/
mL, anti-liver–kidney microsomal antibody (LKM Ab) = 
0.1 U/mL, thyroid function tests were normal, transferrin 
saturation = 43.7%, ferritin = 139 ng/mL, parathormone = 
53 pg/mL (normal range: 13–54), arterial blood gas depicted 
a pH of 7.25, partial pressure of carbon dioxide (pCO2) = 
22 mm Hg, serum chloride = 117 mEq/L (normal range up 
Figure 2: X-ray reveals severe bowing of the upper and lower 
limbs and marked generalized osteopenia.
Zare E et al. 
 Journal of Renal and Hepatic Disorders  2021;5(2): 39–44  42
uricosuria, hypercalciuria, and urinary amino acids were 
not evaluated. In our patient, based on the above-mentioned 
biological and radiological investigations, presence of both 
proximal and distal RTA was arrived at. Notably, because 
urolithiasis is linked with distal type 1 RTA, it was the most 
expected cause of stone development. Hypercalciuria has 
been also described in patients of Wilson’s disease, and uro-
lithiasis exists in about 40% of patients; however, our patient 
did not have hypercalciuria. 
Renal tubular dysfunction is presumed to be due to direct 
defect to the tubular epithelium because of copper, or 
increased absorption of calcium because of skeletal or gas-
trointestinal abnormalities (44).
Osteomalacia is characterized by the remodulation of 
bone mineralization; in patients of Wilson’s disease, it is a 
consequence of dRTA urinary calcium loss and prompted 
acidosis. Even so, osteomalacia induced by RTA is far more 
frequent with proximal tubular function defects (Fanconi’s 
syndrome) in comparison to other renal tubular diseases. 
Proximal RTA rarely occurs as the presenting characteriza-
tion of Wilson’s disease (45, 46).
Multiple musculoskeletal manifestations have been 
described in Wilson’s disease. Early onset of osteoarthritis 
(OA) is the most common musculoskeletal manifestation. 
Osteoarticular changes associated with Wilson’s disease 
include osteoporosis, osteomalacia, and degenerative joint 
diseases, especially of the knees and wrists. Radiography 
shows bone fragmentation, osteoarthritis, joint capsule 
calcification, chondrocalcinosis, osteochondritis dissecans 
(OCD), and subarticular cysts. Some spinal involvements 
could also be encountered in these patients such as verte-
bral body squaring, early lumbar osteoarthritis, and osteo-
chondritis. The present patient demonstrated severe bowing 
deformity of the upper and lower limbs, metaphyseal widen-
ing along with marked generalized osteopenia. Degenerative 
changes in joint, including large osteophytes, patellofem-
oral fusion, loss of joint space, and deformities, could be 
observed in the knees. Similar changes are apparent in other 
large joints. In the wrists, angulation of the carpal bones 
and squaring in the head of metacarpal bones are discov-
ered. Chest X-ray evidenced severe deformity of the rib cage, 
inward bowing of the ribs, and marked kyphoscoliosis. Both 
hemidiaphragms are elevated and limited space was discov-
ered on left of the lungs.
The considered patient had a combined demonstration of 
proximal and distal tubular dysfunction, a combination of 
hypophosphatemia, and acidosis; other injuries from the dis-
ease could be an aggravating factor.
The leading cause of rickets is alterations in vitamin D, 
and not responding adequately to its substitutional treat-
ments. It is, therefore, essential to take into consideration the 
underlying conditions that may cause metabolic bone dis-
eases such as renal tubular dysfunction, leading to disorder 
The major difficulty in establishing the diagnosis of Wil-
son’s disease is it’s infrequent but varied manifestations. Its 
timely diagnosis is crucial for successful treatment.
Although musculoskeletal features may be well-developed 
in Wilson’s disease, this has limited consideration. Accepted 
musculoskeletal manifestations of Wilson’s disease include 
the following: bone demineralization (14), genu varum (15), 
scoliosis (16), synovitis (17), osteochondritis dissecans (18), 
osteomalacia and rickets (19, 20), avascular necrosis of fem-
oral head (21), early osteoarthritis (17), spontaneous fracture 
(21–23), heterotopic ossification (24), osteoporosis (25), and 
epiphyseal dysplasia (26).
Osteomuscular aspect is one of the four key criteria of 
set domains proposed by Global Assessment Scale for Wil-
son’s disease in 2009 (27). Yu et al., in 2017, came out with 
isolated musculoskeletal (osseomuscular) type of Wilson’s 
disease (15).
The diagnosis of Wilson’s disease is based on the results of 
several clinical and biochemical examinations (28–30). Each 
of these diagnostic tests has its limitations, and only a combi-
nation of clinical, biochemical, and genetic examinations cre-
ates a logical criteria for correct diagnosis of Wilson’s disease.
Unexpectedly, the patient presented with proteinuria. 
Despite having osteopaenia on plain radiograph, he had 
normal serum vitamin D levels. Owing to abnormal liver 
function tests and cirrhosis on sonography along with the 
presence of K-F rings on slit lamp examination, Wilson’s 
disease was suspected. Nevertheless, low ceruloplasmin and 
serum copper levels, and high 24-h urinary copper output 
established the diagnosis. In this case, we did not perform 
liver biopsy.
In patients with Wilson’s disease, renal involvement in the 
form of proximal RTA is reported. 
Here, RTA is signified by the presence of normal anion 
gap hyperchloremic metabolic acidosis, and depending on 
the type of RTA, the serum potassium level could be high, 
normal, or low. Distal and proximal tubular function defects 
along with decreased glomerular filtration rate and renal 
plasma flow ameliorated the risk of urolithiasis (31–39). 
 Fanconi’s syndrome (proximal sodium cotransport defect) 
also has been described in these patients (40).
Furthermore, about 70–80% patients of of Wilson’s dis-
ease have been found to have distal RTA, which is proved 
with ammonium acid load test, Whether they have kidney 
stones or not.  (41, 42). In addition, urolithiasis has been 
associated with incomplete distal RTA (43).
In spite of having a systemic nonanion gap, hyperchlor-
emic metabolic acidosis in our patient, anion gap metabolic 
acidosis was normal along with positive urinary anion gap. 
Urinary pH was also maintained above 6.5 in all urinary 
analyses.
Glucosuria in the presence of normal blood sugars 
and hypophosphatemia, hypouricemic in the absence of 
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17. Aslan B, Erdoğan H, Yazısız V. The view of joints in the 
Wilson’s disease. Eur J Rheumatol. 2020 Apr 28;7(4):205–6. 
https://doi.org/10.5152/eurjrheum.2020.19184. Epub ahead of 
print. PMID: 32384047; PMCID: PMC7574760.
18. Merle U, Schaefer M, Ferenci P,Stremmel W. Clinical presenta-
tion, diagnosis and long-term outcome of Wilson’s disease: A 
cohort study. Gut. 2007;56:115–120. https://doi.org/10.1136/
gut.2005.087262 
19. Selvan C, Thukral A, Chakraborthy PP, Rana B, Ajitesh  R, 
Soumik G, et al. Refractory rickets due to Fanconi’s 
Syndrome secondary to Wilson’s disease. Indian J 
Endocrinol Metab. 2012;16(Suppl 2):S399–401. https://doi.
org/10.4103/2230-8210.104107
20. Goyal JP, Kumar N, Rao SS, Shahl VB. Wilson’s disease pre-
senting as resistant rickets. Gastroenterology Res. 2011;4:34–5. 
https://doi.org/10.4021/gr262w
21. Verma R, Junewar V, Sahu R. Pathological fractures as an ini-
tial presentation of Wilson’s disease. BMJ Case Rep 2013; 2013: 
pii: bcr2013008857. https://doi.org/10.1136/ bcr-2013-008857. 
PMID: 23576656.
22. Tsuchiya M, Takaki R, Kobayashi F, Nagasaka T, Shindo K, 
Takiyama Y. Multiple pseudofractures due to Fanconi’s syn-
drome associated with Wilson’s disease. Rinsho Shinkeigaku. 
2017 Sep 30;57(9):527–30. Japanese. https://doi.org/10.5692/
clinicalneurol.cn-000953. Epub 2017 Aug 31. PMID: 28855492.
23. Bhatnagar N, Lingaiah P, Lodhi JS, Karkhur Y. Pathological 
fracture of femoral neck leading to a diagnosis of Wilson’s 
of calcium and phosphate reabsorption and synthesis of 
1,25-dihydroxyvitamin D3.
Wilson’s disease has a tendency to be misdiagnosed, since 
its musculoskeletal manifestations are subtle. 
A review of Indian patients reported refractory rickets 
and renal tubular diseases in approximately one-third of the 
cases of 25 patients with WD (47, 48).
In a meta-analysis limited only to adult patients of Wil-
son’s disease, the estimated prevalence rate of osteoporosis, 
osteopenia, and vertebral fracture was 17.6%, 50.0%, and 
8.01%, respectively (49).
Rickets has been described infrequently as a presenting 
feature of Wilson’s disease. Understanding of this entity is 
essential, as therapy may improve primary condition and 
renal involvement such as Fanconi’s syndrome due to Wil-
son’s disease as well as related biological and clinical mani-
festations and tubular functions (50–52).
The presented patient had been suffering from renal stones 
for many years; however, since he was never evaluated for the 
precise etiology of urolithiasis and underlying diseases, this 
problem remained concealed.
Thus, in the present patient, role of urologists/nephrolo-
gists in the early diagnosis and treatment of RTA and under-
lying diseases, such as Wilson’s disease, in a timely manner, 
has been highlighted. Unfortunately, late diagnosis, severity 
of the disease, and adverse effects significantly affected our 
patient’s life style and physical appearance.
In spite of the rarity of the manifestations of Wilson’s dis-
ease, we emphasize that in case of recurrent or resistant uro-
lithiasis, the main etiology must be examined thoroughly. In 
any patient presenting questionable symptoms, diagnosis of 
Wilson’s disease must be taken as a top consideration. 
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